Alterome Therapeutics
AcquiredHome - Alterome
San Diego, United States · Founded 2021 · $231.0M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- alterome.com
- Total Funding
- $231.0M
- Last Round
- $132.0M Series BApr 2024
- Rounds
- 3
About
Alterome Therapeutics is a clinical-stage precision oncology company founded in 2021 and headquartered in San Diego, California. The company is developing first-in-class, alteration-specific therapies targeting AKT E17K- and KRAS-driven cancers, aiming to deliver safer and more precise treatments. Alterome has raised over million to advance its pipeline of novel oncology candidates.
Summary
Alterome Therapeutics is a Biotech company based in San Diego, United States, founded in 2021. It has raised $231.0M in total across 3 rounds, most recently a $132.0M Series B round in Apr 2024.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform